Ulocuplumab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Ulocuplumab, covering 2017-08-28 to 2024-05-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia [Phase 1]